- Home
- XENE vs PII Comparison
XENE vs PII Comparison
Compare XENE & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | PII |
|---|---|---|
| Founded | 1996 | 1954 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.2B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XENE | PII |
|---|---|---|
| Price | $62.35 | $69.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 11 |
| Target Price | ★ $68.55 | $62.27 |
| AVG Volume (30 Days) | 654.5K | ★ 821.0K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 4.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $311,000.00 | ★ $7,152,000,000.00 |
| Revenue This Year | N/A | $1.20 |
| Revenue Next Year | $2,496.48 | $4.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.60 | $47.14 |
| 52 Week High | $72.66 | $77.98 |
Technical Indicators
Market Signals| Indicator | XENE | PII |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 46.48 |
| Support Level | $61.16 | $63.61 |
| Resistance Level | $62.91 | $70.89 |
| Average True Range (ATR) | 2.15 | 3.27 |
| MACD | -0.39 | -0.42 |
| Stochastic Oscillator | 19.72 | 23.90 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.